EXACT Sciences Net Income vs. Return On Asset
| EXAS Stock | USD 104.91 -1,763 -94.38% |
Net Loss | First Reported 2000-03-31 | Previous Quarter -19.6 M | Current Value -86 M | Quarterly Volatility 103.3 M |
Macro event markers
Profitability metrics for EXACT Sciences relate earnings to revenue, assets, and equity. All profitability ratios are based on historical financial data.
Segment Revenue Breakdown
EXACT Sciences generates revenue across 2 reported product segments. The largest contributor is Screening at 1.24 Billion (77.9% of revenue), with Precision Oncology accounting for 350.02 Million (22.1%). Revenue concentration above 60% in one segment means EXACT Sciences' performance is closely tied to that product's market dynamics.
Investing Opportunities.
Macro event markers
Revenue Breakdown by Earning Segment for EXACT Sciences Summary
This chart illustrates EXACT Sciences' revenue composition by product line based on the latest available data. At 22.1%, Precision Oncology is the narrowest segment in EXACT Sciences' product mix.
These projections help frame the earnings trajectory for EXACT Sciences across periods. The data is presented for reference alongside other available performance metrics.
Earnings Share -1.10 | Revenue Per Share | Quarterly Revenue Growth 0.231 | Return On Assets | Return On Equity |
The gap between EXACT Sciences' market value and book value reflects how the market perceives future potential versus historical cost.
Understanding EXACT Sciences involves recognizing that value and price can reflect different time horizons. All metrics are derived from available inputs and shown for reference.
EXACT Sciences Return On Asset vs. Net Income Fundamental Analysis
Peer multiple analysis evaluates EXACT Sciences's pricing efficiency within its industry. EXACT Sciences maintains a fifth standing in net income relative to competitors. It is rated below average in return on asset relative to competitors . Comparative financial data indicate that Net Loss is shifting by roughly 4.76%. A year ago, EXACT Sciences reported Net Loss at -207.95 Million. Valuation multiples such as P/E, P/B, and P/S compare EXACT Sciences to peer earnings performance.EXACT Return On Asset vs. Net Income
Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.
EXACT Sciences |
| = | -207.95 M |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
Return on Assets (ROA) measures how efficiently a company generates profit relative to its total asset base. It is calculated by dividing net income by total assets and reflects management's effectiveness at deploying capital across the business. ROA is particularly useful for comparing companies within the same industry, since asset intensity varies widely across sectors.
EXACT Sciences |
| = | -0.0159 |
A higher ROA indicates that each dollar of assets produces more income, which generally signals operational efficiency. Asset-heavy industries such as banking, utilities, and manufacturing tend to have lower ROAs than asset-light businesses like software or professional services. When ROA is low, it may indicate either underperforming operations or a capital-intensive business model that requires ongoing investment to sustain revenue.
EXACT Return On Asset Comparison
EXACT Sciences is currently under evaluation in return on asset relative to competitors.
EXACT Sciences Profitability Projections
Profits drive shareholder value, and EXACT Sciences' profit trends deserve careful review. A falling profit trend for EXACT Sciences can signal weak results and may point to future losses. EXACT Sciences currently maintains a profit margin of -6.4%. Profits that lean heavily on non-core items may not last in the long run. The operating margin stands at -9.3% while return on equity is -8.7%.
| Last Reported | End Of Year Estimate | ||
| Accumulated Other Comprehensive Income | 2.4 M | 2.5 M | |
| Operating Income | -99.1 M | -104 M | |
| Net Loss | -207.9 M | -218.3 M | |
| Income Tax Expense | 4.1 M | 3.9 M | |
| Income Before Tax | -203.9 M | -214.1 M | |
| Total Other Income Expense Net | -104.8 M | -99.6 M | |
| Net Loss | -207.9 M | -218.3 M | |
| Non Operating Income Net Other | -22.3 M | -21.2 M | |
| Net Loss | -561.2 M | -533.1 M | |
| Interest Income | 28.1 M | 29.5 M | |
| Net Interest Income | -39.4 M | -41.3 M | |
| Change To Netincome | 208.5 M | 131.1 M | |
| Net Loss | -1.10 | -1.16 | |
| Income Quality | -2.36 | -2.25 | |
| Net Income Per E B T | 1.02 | 0.67 |
EXACT Profitability Driver Comparison
Profitability drivers are factors that directly affect the investment outlook for EXACT Sciences. Investors holding EXACT Sciences' stock face unpredictable events that can materially affect the company's earnings.
Earnings Estimation Breakdown
The calculation of EXACT Sciences' earnings per share is based on data from the past 12 consecutive months used for reporting the company's financial figures. The next projected EPS of EXACT Sciences is estimated to be 0.05 with the future projection ranging from a low of 0.05 to a high of 0.05. Please be aware that this consensus of annual earnings estimates for EXACT Sciences is based on EPS before non-recurring items.Last Reported EPS
0.05 Lowest | Expected EPS | 0.05 Highest |
Earnings Projection Consensus
A consensus EPS-based estimate above EXACT Sciences' current price may suggest the market is pricing in excessive pessimism or overlooking near-term catalysts. Conversely, an estimate below market price could reflect a premium valuation that requires sustained earnings growth to justify. Both interpretations demand risk assessment and should not be acted upon in isolation.
| Number of Analysts | Historical Accuracy | Last Reported EPS | Estimated EPS for 31st of March 2026 | Current EPS (TTM) | |
| 12 | 56.1% | -0.21 | 0.05 | -1.1 |
Earnings per Share Projection vs Actual
When EXACT Sciences reports actual EPS, investors compare it against the analyst consensus estimate for EXACT Sciences to judge performance. A beat versus consensus is typically interpreted as positive execution; a miss signals a shortfall relative to expectations. EPS is expressed on a weighted average per-share basis to account for equity changes within the reporting period.Estimated Months Earnings per Share
EPS serves income investors in EXACT Sciences as a quick gauge of dividend affordability: the higher the EPS relative to the dividend per share, the more cushion management has. However, accounting EPS can diverge from cash-based earnings, so investors should validate EPS signals with operating cash flow and capex data. Comparing EXACT Sciences' EPS to sector peers provides further context for dividend sustainability.Quarterly Analyst Estimates and Surprise Metrics
Earnings surprise history for EXACT Sciences' reveals whether the company tends to guide conservatively or struggles to meet analyst expectations. A pattern of consistent beats signals strong management execution; repeated misses may indicate structural challenges. Analyst EPS estimates are formed from a combination of forward guidance, sector trends, and macroeconomic inputs.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2026-02-13 | 2025-12-31 | 0.08 | -0.21 | -0.29 | 362 | ||
2025-11-03 | 2025-09-30 | 0.16 | 0.24 | 0.08 | 50 | ||
2025-08-06 | 2025-06-30 | -0.13 | -0.01 | 0.12 | 92 | ||
2025-05-06 | 2025-03-31 | -0.47 | -0.358 | 0.112 | 23 | ||
2025-02-19 | 2024-12-31 | -0.3327 | -0.2404 | 0.0923 | 27 | ||
2024-11-05 | 2024-09-30 | -0.21 | -0.21 | 0.0 | 0 | ||
2024-07-31 | 2024-06-30 | -0.24 | -0.06 | 0.18 | 75 | ||
2024-05-08 | 2024-03-31 | -0.41 | -0.54 | -0.13 | 31 | ||
2024-02-21 | 2023-12-31 | -0.36 | -0.43 | -0.07 | 19 | ||
2023-11-01 | 2023-09-30 | -0.43 | -0.32 | 0.11 | 25 | ||
2023-08-01 | 2023-06-30 | -0.41 | -0.35 | 0.06 | 14 | ||
2023-05-09 | 2023-03-31 | -0.66 | -0.35 | 0.31 | 46 | ||
2023-02-21 | 2022-12-31 | -0.78 | -0.56 | 0.22 | 28 | ||
2022-11-03 | 2022-09-30 | -1.05 | -0.74 | 0.31 | 29 | ||
2022-08-02 | 2022-06-30 | -1.04 | -0.93 | 0.11 | 10 | ||
2022-04-26 | 2022-03-31 | -1.04 | -1.18 | -0.14 | 13 | ||
2022-02-22 | 2021-12-31 | -0.88 | -1.28 | -0.4 | 45 | ||
2021-11-02 | 2021-09-30 | -0.83 | -0.74 | 0.09 | 10 | ||
2021-07-28 | 2021-06-30 | -0.72 | -0.76 | -0.04 | 5 | ||
2021-05-04 | 2021-03-31 | -0.94 | -0.07 | 0.87 | 92 | ||
2021-02-16 | 2020-12-31 | -0.26 | -0.1 | 0.16 | 61 | ||
2020-10-27 | 2020-09-30 | -0.57 | -0.05 | 0.52 | 91 | ||
2020-07-30 | 2020-06-30 | -0.65 | -0.69 | -0.04 | 6 | ||
2020-05-06 | 2020-03-31 | -0.52 | -0.66 | -0.14 | 26 | ||
2020-02-11 | 2019-12-31 | -0.36 | -0.76 | -0.4 | 111 | ||
2019-10-29 | 2019-09-30 | -0.41 | -0.31 | 0.1 | 24 | ||
2019-07-29 | 2019-06-30 | -0.56 | -0.3 | 0.26 | 46 | ||
2019-04-30 | 2019-03-31 | -0.65 | -0.66 | -0.01 | 1 | ||
2019-02-21 | 2018-12-31 | -0.48 | -0.44 | 0.04 | 8 | ||
2018-10-30 | 2018-09-30 | -0.43 | -0.37 | 0.06 | 13 | ||
2018-08-01 | 2018-06-30 | -0.32 | -0.3 | 0.02 | 6 | ||
2018-04-26 | 2018-03-31 | -0.38 | -0.33 | 0.05 | 13 | ||
2018-02-22 | 2017-12-31 | -0.24 | -0.18 | 0.06 | 25 | ||
2017-10-30 | 2017-09-30 | -0.3 | -0.23 | 0.07 | 23 | ||
2017-07-25 | 2017-06-30 | -0.35 | -0.27 | 0.08 | 22 | ||
2017-04-27 | 2017-03-31 | -0.41 | -0.32 | 0.09 | 21 | ||
2017-02-21 | 2016-12-31 | -0.39 | -0.34 | 0.05 | 12 | ||
2016-10-26 | 2016-09-30 | -0.42 | -0.36 | 0.06 | 14 | ||
2016-07-26 | 2016-06-30 | -0.55 | -0.46 | 0.09 | 16 | ||
2016-05-03 | 2016-03-31 | -0.52 | -0.49 | 0.03 | 5 | ||
2016-02-24 | 2015-12-31 | -0.47 | -0.41 | 0.06 | 12 | ||
2015-10-29 | 2015-09-30 | -0.44 | -0.45 | -0.01 | 2 | ||
2015-07-20 | 2015-06-30 | -0.44 | -0.44 | 0.0 | 0 | ||
2015-05-04 | 2015-03-31 | -0.41 | -0.4 | 0.01 | 2 | ||
2015-02-24 | 2014-12-31 | -0.39 | -0.38 | 0.01 | 2 | ||
2014-10-27 | 2014-09-30 | -0.31 | -0.39 | -0.08 | 25 | ||
2014-07-22 | 2014-06-30 | -0.24 | -0.24 | 0.0 | 0 | ||
2014-05-01 | 2014-03-31 | -0.19 | -0.23 | -0.04 | 21 | ||
2014-02-20 | 2013-12-31 | -0.19 | -0.17 | 0.02 | 10 | ||
2013-10-29 | 2013-09-30 | -0.18 | -0.16 | 0.02 | 11 | ||
2013-07-23 | 2013-06-30 | -0.18 | -0.19 | -0.01 | 5 | ||
2013-05-01 | 2013-03-31 | -0.19 | -0.17 | 0.02 | 10 | ||
2013-02-20 | 2012-12-31 | -0.18 | -0.22 | -0.04 | 22 | ||
2012-10-30 | 2012-09-30 | -0.21 | -0.21 | 0.0 | 0 | ||
2012-07-25 | 2012-06-30 | -0.2 | -0.26 | -0.06 | 30 | ||
2012-05-01 | 2012-03-31 | -0.18 | -0.19 | -0.01 | 5 | ||
2012-02-23 | 2011-12-31 | -0.17 | -0.18 | -0.01 | 5 | ||
2011-11-03 | 2011-09-30 | -0.14 | -0.15 | -0.01 | 7 | ||
2011-08-02 | 2011-06-30 | -0.1 | -0.13 | -0.03 | 30 | ||
2011-05-03 | 2011-03-31 | -0.1 | -0.08 | 0.02 | 20 | ||
2011-02-15 | 2010-12-31 | -0.08 | -0.08 | 0.0 | 0 | ||
2010-10-27 | 2010-09-30 | -0.07 | -0.08 | -0.01 | 14 | ||
2010-07-28 | 2010-06-30 | -0.06 | -0.06 | 0.0 | 0 | ||
2010-05-06 | 2010-03-31 | -0.06 | -0.06 | 0.0 | 0 | ||
2010-02-16 | 2009-12-31 | -0.05 | -0.05 | 0.0 | 0 | ||
2006-07-24 | 2006-06-30 | -0.14 | -0.12 | 0.02 | 14 | ||
2006-04-24 | 2006-03-31 | -0.13 | -0.14 | -0.01 | 7 | ||
2006-01-23 | 2005-12-31 | -0.13 | -0.1 | 0.03 | 23 | ||
2005-10-24 | 2005-09-30 | -0.12 | -0.13 | -0.01 | 8 | ||
2005-07-25 | 2005-06-30 | -0.15 | -0.15 | 0.0 | 0 | ||
2005-04-25 | 2005-03-31 | -0.17 | -0.15 | 0.02 | 11 | ||
2005-01-24 | 2004-12-31 | -0.18 | -0.17 | 0.01 | 5 | ||
2004-10-25 | 2004-09-30 | -0.19 | -0.17 | 0.02 | 10 | ||
2004-07-26 | 2004-06-30 | -0.21 | -0.16 | 0.05 | 23 | ||
2004-04-26 | 2004-03-31 | -0.24 | -0.23 | 0.01 | 4 | ||
2004-01-26 | 2003-12-31 | 0.34 | -0.29 | -0.63 | 185 | ||
2003-10-27 | 2003-09-30 | -0.36 | -0.34 | 0.02 | 5 | ||
2003-07-21 | 2003-06-30 | -0.41 | -0.4 | 0.01 | 2 | ||
2003-04-28 | 2003-03-31 | -0.39 | -0.4 | -0.01 | 2 | ||
2003-01-27 | 2002-12-31 | -0.36 | -0.36 | 0.0 | 0 | ||
2002-10-21 | 2002-09-30 | -0.35 | -0.37 | -0.02 | 5 | ||
2002-07-22 | 2002-06-30 | -0.39 | -0.4 | -0.01 | 2 | ||
2002-04-22 | 2002-03-31 | -0.36 | -0.39 | -0.03 | 8 | ||
2002-01-30 | 2001-12-31 | -0.37 | -0.32 | 0.05 | 13 | ||
2001-10-22 | 2001-09-30 | -0.32 | -0.27 | 0.05 | 15 | ||
2001-07-23 | 2001-06-30 | -0.27 | -0.26 | 0.01 | 3 | ||
2001-04-25 | 2001-03-31 | -0.26 | -0.27 | -0.01 | 3 | ||
2001-03-13 | 2000-12-31 | -0.37 | -0.25 | 0.12 | 32 |
Use EXACT Sciences in pair-trading
Pair trading with EXACT Sciences can help investors hedge some company-specific exposure by balancing a long view with an offsetting position. The key question is whether the second leg adds real hedge value instead of just creating a more complex version of the same risk.
EXACT Sciences Pair Trading
EXACT Sciences Pair Trading Analysis
Finding closely correlated positions to EXACT Sciences provides context for tax-loss harvesting analysis. Selling EXACT Sciences at a loss and repurchasing it immediately would violate IRS wash-sale rules.
The correlation of EXACT Sciences is a statistical measure of how it moves in relation to other instruments. Values near +1 indicate near-identical movement to EXACT Sciences, while values near -1 suggest inverse movement.
Use Correlation analysis and pair trading evaluation for EXACT Sciences to review hedging context.Use Investing Themes to Complement your EXACT Sciences position
EXACT Sciences Healthcare sector classification and 20.03 Billion mid-cap scale make it a natural anchor for themes targeting Diagnostics & Research exposure. Building a Healthcare theme from EXACT Sciences 20.03 Billion position turns a single Diagnostics & Research conviction into a risk-managed basket.
Did You Try This Idea?
Run Energy ETFs Thematic Idea Now
Energy ETFs
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Energy ETFs theme has 99 constituents at this time.
Investors can hold the Energy ETFs Theme as a long-term basket or actively trade individual constituents to capture short-term price movement.
| View All Next | Launch |
Additional Tools for EXACT Stock Analysis
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios |